NM_021252.5:c.-20C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021252.5(RAB18):​c.-20C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00088 in 1,568,688 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 1 hom. )

Consequence

RAB18
NM_021252.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.592

Publications

1 publications found
Variant links:
Genes affected
RAB18 (HGNC:14244): (RAB18, member RAS oncogene family) The protein encoded by this gene is a member of a family of Ras-related small GTPases that regulate membrane trafficking in organelles and transport vesicles. Knockdown studies is zebrafish suggest that this protein may have a role in eye and brain development. Mutations in this gene are associated with Warburg micro syndrome type 3. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
RAB18 Gene-Disease associations (from GenCC):
  • Warburg micro syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Warburg micro syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 10-27504350-C-T is Benign according to our data. Variant chr10-27504350-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 299813.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00408 (621/152324) while in subpopulation AFR AF = 0.0138 (573/41580). AF 95% confidence interval is 0.0128. There are 3 homozygotes in GnomAd4. There are 287 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAB18NM_021252.5 linkc.-20C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 7 ENST00000356940.11 NP_067075.1 Q9NP72-1
RAB18NM_021252.5 linkc.-20C>T 5_prime_UTR_variant Exon 1 of 7 ENST00000356940.11 NP_067075.1 Q9NP72-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAB18ENST00000356940.11 linkc.-20C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 7 1 NM_021252.5 ENSP00000349415.7 Q9NP72-1
RAB18ENST00000356940.11 linkc.-20C>T 5_prime_UTR_variant Exon 1 of 7 1 NM_021252.5 ENSP00000349415.7 Q9NP72-1

Frequencies

GnomAD3 genomes
AF:
0.00407
AC:
620
AN:
152206
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00124
AC:
227
AN:
182456
AF XY:
0.00100
show subpopulations
Gnomad AFR exome
AF:
0.0160
Gnomad AMR exome
AF:
0.000651
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000233
Gnomad OTH exome
AF:
0.00185
GnomAD4 exome
AF:
0.000536
AC:
759
AN:
1416364
Hom.:
1
Cov.:
31
AF XY:
0.000507
AC XY:
355
AN XY:
699992
show subpopulations
African (AFR)
AF:
0.0157
AC:
515
AN:
32890
American (AMR)
AF:
0.000920
AC:
34
AN:
36972
Ashkenazi Jewish (ASJ)
AF:
0.0000396
AC:
1
AN:
25284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38054
South Asian (SAS)
AF:
0.000186
AC:
15
AN:
80496
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49830
Middle Eastern (MID)
AF:
0.00419
AC:
19
AN:
4540
European-Non Finnish (NFE)
AF:
0.0000881
AC:
96
AN:
1089556
Other (OTH)
AF:
0.00134
AC:
79
AN:
58742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00408
AC:
621
AN:
152324
Hom.:
3
Cov.:
32
AF XY:
0.00385
AC XY:
287
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0138
AC:
573
AN:
41580
American (AMR)
AF:
0.00209
AC:
32
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
28
56
85
113
141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00216
Hom.:
0
Bravo
AF:
0.00483
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 11, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Warburg micro syndrome 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
12
DANN
Benign
0.89
PhyloP100
-0.59
PromoterAI
-0.13
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74127323; hg19: chr10-27793279; API